NCT07395973

Brief Summary

This study will investigate the effect of providing a daily ketogenic nutritional supplement in the evening for a prolonged time (4 weeks) to induce a mild ketogenic state during the night in healthy elderly (60-80 years), overweight/obese (BMI: 25-35 kg/m2) individuals with low physical activity, on 24h rhythmicity in energy metabolism as compared to a non-ketogenic, isocaloric control.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
16mo left

Started Nov 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Nov 2025Oct 2027

First Submitted

Initial submission to the registry

September 8, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

November 25, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 9, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2027

Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

1.9 years

First QC Date

September 8, 2025

Last Update Submit

February 3, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Delta respiratory exchange ratio (from 23:00 till 04:00)

    Measured with indirect calorimetry

    Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control

Secondary Outcomes (1)

  • Skeletal mitochondrial function

    Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control

Other Outcomes (11)

  • Protein and gene markers of skeletal muscle metabolism

    Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control

  • Metabolic blood markers

    Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control

  • Interstitial ketone levels

    Measured after 4 weeks of daily supplementation with a ketogenic nutritional supplement or non-ketogenic, isocaloric control

  • +8 more other outcomes

Study Arms (2)

Ketogenic nutritional supplement

EXPERIMENTAL

Daily ketogenic nutritional supplement for 4 weeks

Dietary Supplement: ketogenic nutritional Supplement

non-ketogenic, isocaloric control

PLACEBO COMPARATOR

Daily control for 4 weeks

Dietary Supplement: non-ketogenic, isocaloric control

Interventions

Daily ketogenic nutritional supplement for 4 weeks

Ketogenic nutritional supplement

Daily control for 4 weeks

non-ketogenic, isocaloric control

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 60-80 years
  • Body mass index (BMI) 25-35 kg/m2
  • Sedentary lifestyle (not more than 2 hours of structured physical activity per week in the past 3 months)
  • Stable dietary habits (no weight loss or gain \> 5 kg in the past 3 months)
  • Healthy (as determined by dependent physician based on medical questionnaire)
  • Regular sleeping habits (7-9h of daily sleep)

You may not qualify if:

  • Type 2 diabetes
  • Participants with active congestive heart failure and/or severe renal and or liver insufficiency
  • Uncontrolled hypertension
  • Alcohol consumption of \>3 servings per day for men and \>2 servings per day for women
  • Unstable body weight (weight gain or loss \> 5 kg in the last 3 months) or intention to lose weight
  • Participants who are on an intermittent fasting diet
  • Previous enrolment in a clinical study with an investigational product during the last 3 months or as judged by the investigator which would possibly hamper our study results
  • Significant food allergies/intolerance (seriously hampering study meals or study product)
  • Participants who do not want to be informed about unexpected medical findings
  • Blood donation during or within 2 months prior to the study
  • Disturbances in circadian rhythm determined with the follow criteria:
  • Extreme early bird or extreme night person (score ≤30 or ≥70 on MEQ-SA questionnaire)
  • Heavily varying sleep-wake rhythm
  • Night shift work during last 3 months
  • Travel across \> 1 time zone in the last 3 months
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University

Maastricht, Netherlands

RECRUITING

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Joris Hoeks, Dr.

    Maastricht University

    PRINCIPAL INVESTIGATOR
  • Peter Joris, Dr.

    Maastricht University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joris Hoeks, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2025

First Posted

February 9, 2026

Study Start

November 25, 2025

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

October 31, 2027

Last Updated

February 9, 2026

Record last verified: 2026-02

Locations